primary ciliary dyskinesia pcd genetic disease characterized abnormal ciliary structure function impaired mucociliary clearance patients pcd use cough clearance airway defense mechanism tested hypothesis aerosolized utp improve clearance cough actions stimulate secretion mucin release goblet cells measured clearance cough NUMBER patients pcd ages NUMBER NUMBER yr fev1 NUMBER NUMBER predicted double blind randomized crossover study aerosolization single dose utp NUMBER NUMBER ml vehicle NUMBER saline NUMBER ml clearance cough lung quantified series controlled coughs measuring clearance 99mtcfe2o3 particles gamma camera scanning NUMBER min safety parameters recorded drug delivery aerosolized utp improved clearance cough compared vehicle NUMBER NUMBER min NUMBER utp versus NUMBER NUMBER vehicle mean sem p NUMBER NUMBER NUMBER min NUMBER utp versus NUMBER min vehicle p NUMBER NUMBER aerosolized utp safe adverse effects clearance cough patients defective ciliary function enhanced inhalation utp uridine NUMBER triphosphate cl lung lung mg ml NUMBER min NUMBER min NUMBER min NUMBER